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Swallow EB, Gosker HR, Ward KA, Moore AJ, Dayer MJ,
Hopkinson NS, Schols AM, Moxham J, Polkey MI. A novel
technique for nonvolitional assessment of quadriceps muscle endur-
ance in humans. J Appl Physiol 103: 739–746, 2007. First published
June 14, 2007; doi:10.1152/japplphysiol.00025.2007.—Assessment
of quadriceps endurance is of interest to investigators studying human
disease. We hypothesized that repetitive magnetic stimulation (rMS)
of the intramuscular branches of the femoral nerve could be used to
induce and quantify quadriceps endurance. To test this hypothesis, we
used a novel stimulating coil to compare the quadriceps endurance
properties in eight normal humans and, to confirm that the technique
could be used in clinical practice, in eight patients with advanced
chronic obstructive pulmonary disease (COPD). To validate the
method, we compared in vivo contractile properties of the quadriceps
muscle with the fiber-type composition and oxidative enzyme capac-
ity. We used a Magstim Rapid2 magnetic nerve stimulator with the
coil wrapped around the quadriceps. Stimuli were given at 30 Hz, a
duty cycle of 0.4 (2 s on, 3 s off), and for 50 trains. Force generation
and the surface electromyogram were measured throughout. Quadri-
ceps twitch force, elicited by supramaximal magnetic stimulation of
the femoral nerve, was measured before and after the protocol.
Quadriceps muscle biopsies were analyzed for oxidative (citrate
synthase, CS) and glycolytic (phosphofructokinase, PFK) enzyme
activity and myosin heavy chain isoform protein expression. The time
for force to fall to 70% of baseline (T70) was shorter in the COPD
group than the control group: 55.6  26.0 vs. 121  38.7 s (P 
0.0014). Considering patients and controls together, positive correla-
tions were observed between T70 and the proportion of type I fibers
(r  0.68, P  0.004) and CS-to-PFK ratio (CS/PFK) (r  0.67, P 
0.005). We conclude that quadriceps endurance assessed using rMS is
feasible in clinical studies.
skeletal muscle fatigue; magnetic stimulation; myosin heavy chains;
oxidative capacity
QUADRICEPS WEAKNESS, usually expressed as a function of body
weight, is increasingly recognized as a marker of morbidity
and mortality in a variety of conditions, including chronic
obstructive pulmonary disease (COPD) (34) and congestive
cardiac failure (16), and indeed in unselected elderly humans in
general (24). Some emerging therapies are aimed at improving
quadriceps function (10), and so accurate assessment of quad-
riceps contractility is likely to be useful to investigators study-
ing human disease in vivo. We previously described the tech-
nique of supramaximal magnetic stimulation of the femoral
nerve (30) and showed that it could be used to study patients
with serious medical conditions, including COPD (29) and
stroke (15). However, while this technique has the advantage
that the data obtained are independent of patient aptitude or
motivation, it offers no information regarding the endurance
properties of the muscle.
Endurance is a different quality from strength; while recent
guidelines (3) recognize that endurance and strength are some-
times linked, many examples exist where this is not so. Current
methods used to assess quadriceps endurance require the sub-
ject to make repeated quadriceps contractions, and it is as-
sumed that patients are able to achieve maximal efforts (or
make sequential efforts of equal intensity) (1, 8, 11, 20, 33).
However, central drive to contracting peripheral muscle can be
influenced by exercise (9, 36) or hypoxia (38), which would
influence measured endurance. In addition, it is likely that
patients with serious medical illness would fail to generate
sequential maximal efforts; indeed, where this has been ex-
plored using twitch interpolation, investigators have found it
consistently difficult to ensure efforts are truly maximal even in
healthy humans (2). Even when maximal activation is ensured,
it is known that neuronal discharge frequency reduces progres-
sively during a voluntary effort (6) so that the measured force
is a result both of rate and recruitment patterns quite apart from
intrinsic properties of the muscle.
In contrast, the intrinsic endurance properties of a muscle
can be assessed by the rate at which tension generation declines
during repeated nerve stimulation. Repetitive stimuli at high
intensity given to the femoral nerve in the femoral triangle are,
in our experience, painful, and it is difficult to preserve con-
stancy of stimulation because of movement of the coil relative
to the nerve. We therefore designed a novel, flexible, flat oval
coil that allows direct and repetitive magnetic stimulation of
the quadriceps via the intramuscular branches of the femoral
nerve. This approach produces a contraction of the muscle that
is well tolerated, and we hypothesized that repetitive magnetic
stimuli (rMS), given in this fashion, would induce a progres-
sive failure of quadriceps tension generation and could thus be
used as a nonvolitional test of endurance. Because of the issues
of rate and recruitment noted above, we did not believe that
rMS could appropriately be tested against a volitional protocol.
Therefore we aimed in the present study to address three
questions: first, could rMS be used practically and reproducibly
as a nonvolitional method of assessing failure of quadriceps
tension generation in vivo; second, could rMS distinguish the
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endurance properties of the quadriceps muscle of COPD pa-
tients compared with healthy age-matched controls; and third,
were the endurance properties of the quadriceps muscle related
to fiber-type composition and oxidative enzyme content.
METHODS
Subjects. Eight male patients with advanced COPD classified
according to the GOLD criteria (26), in whom quadriceps dysfunction
was likely (even though they were without significant comorbidity or
evidence of exacerbation in the preceding month), and eight healthy
age-matched men were studied. The Royal Brompton Hospital Re-
search Ethics Committee approved the study, and all subjects pro-
vided written, informed consent. Anthropometric measurements, fat-
free mass determined by bioelectrical impedance analysis, pulmonary
function tests, and the Yale Physical Activity Survey (YPAS) were
recorded in all subjects (8).
Quadriceps measurements and study protocol. Subjects were stud-
ied supine, with the knee flexed at 90° over the end of the bed. The
ankle of the dominant leg was placed in an inextensible strap that was
connected to a transducer (Strainstall, Cowes, UK) and carrier ampli-
fier (Minograf). The signals were recorded on a computer running
LabView 4.1 software (National Instruments, Austin, TX) and sam-
pling at 100 Hz.
The study protocol is illustrated in Fig. 1. Before the endurance
protocol was started, quadriceps strength was measured by supramaxi-
mal magnetic stimulation of the femoral nerve [quadriceps twitch
force (TwQ)] and by maximal isometric voluntary contraction
(QMVC) following a 20-min rest period for depotentiation. Femoral
nerve stimulation was achieved unilaterally according to a previously
described technique (30). We used a double Magstim 200 magnetic
stimulator, discharging both units simultaneously at 100% of power
output (Magstim, Whitlands, Dyfed, Wales, UK) through a 70-mm
“branding iron” coil (Prototype coil, Magstim) positioned high in the
femoral triangle; values reported are a mean of seven stimuli. Supra-
maximality with this technique has been demonstrated in previous
studies (15, 32). The optimal coil position was outlined in indelible
marker at the start of the experiment, and supramaximality was
confirmed in each subject. QMVC was also performed supine, and the
force generated was visible to subject and investigator for positive
feedback. Repeated efforts (minimum of 3) were made with vigorous
encouragement until there was no improvement in performance; the
biggest effort recorded was used for analysis. Efforts were sustained
for at least 5 s. Subjects rested for 30 s between each contraction.
Surface electromyographic (EMG) signals were recorded during TwQ
stimulation given before and after rMS. A schematic diagram and
photograph of the equipment is shown in Fig. 2.
For the endurance protocol, we used a Magstim Rapid2 magnetic
nerve stimulator system with a specially designed flexible, flat oval
coil (31  28 cm) wrapped around the quadriceps muscle. The coil
consisted of an elliptical shaped coil with nine concentric insulated
copper rings encased in silicone. A space was left between the exterior
of the insulation and the silicone to allow pumping of a cooling fluid,
3-ethoxy-1,1,1,2,3,4,4,5,5,6,6,6-dodecafluoro-2-triflouromethyl-hex-
ane. The stimulator was set at a frequency of 30 Hz, a duty cycle of
0.4 (2 s on, 3 s off), and for 50 trains (250 s). The stimulator intensity
was adjusted for each subject so as to initially generate 30% of their
supine QMVC. Force production was measured continually during the
endurance protocol. Twitch quadriceps force and QMVC were remea-
sured at 10 min after rMS. Nine subjects (4 patients and 5 controls)
were restudied on separate days to assess reproducibility.
EMG recording. Surface recordings of the rectus femoris response
to magnetic stimulation (TwQ) before and after the rMS protocol were
obtained using disposable skin-taped silver electrodes (Sensi-Prema
neonatal ECG electrodes, Maersk Medical, Stonehouse, UK). The
EMG signals evoked by femoral nerve stimulation (termed compound
muscle action potential, CMAP) in the inguinal triangle were ampli-
fied, recorded at 20 kHz, band-pass filtered between 0.3 and 3 kHz,
and stored using a Synergy portable EMG machine (Synergy V4.0,
Medelec, Oxford Instruments). The magnetic stimulator triggered the
EMG machine, so that each stimulation elicited an EMG response that
was recorded and the peak-to-peak amplitude measured. The rectus
femoris activity was recorded from electrodes placed over the belly of
the muscle in its long axis (37).
Quadriceps muscle biopsy. A percutaneous needle biopsy of the
vastus lateralis of the contralateral (i.e., nondominant) leg to the
endurance study (4) was performed in all subjects. Using standard
procedures in the Maastricht laboratory (12), samples were immedi-
ately frozen in liquid nitrogen and stored at 80°C until further
processing. For analyses, a 5% (wt/vol) homogenate was prepared by
dispersion (Polytron PT 1600 E, Kinematica, Lucerne, Switzerland)
followed by 1 min sonication (Branson 2210, Branson Ultrasonics,
Danbury, CT) of the tissue in SET buffer (250 mM sucrose, 2 mM
EDTA, 10 mM Tris, pH 7.4). Samples were centrifuged (10 min,
10,000 g, 4°C), and the supernatant was used for enzyme activity
assays: phosphofructokinase (PFK; EC 2.7.11), 3-hydroxyacyl-CoA
dehydrogenase (HAD; EC 1.1.1.35), citrate synthase (CS; EC
2.3.3.1), and glycogen phosphorylase (GlyP; EC 2.4.1.1), were ana-
lyzed spectrophotometrically (Multiskan Spectrum, Thermo Lab-
systems, Breda, The Netherlands). The remaining pellet was resus-
pended in three volumes of ice-cold extraction buffer (100 mM
Na4O7P2 10H2O, 5 mM EDTA, 1 mM DTT, pH 8.5), incubated on
ice for 30 min, and centrifuged (10 min, 10,000 g, 4°C). From this, the
supernatant was used for myosin heavy chain (MyHC) isoform
analysis. Gels were run for 22 h using a Protean II xi Cell Gelectro-
phoresis system (Bio-Rad, Veenendaal, The Netherlands) at 20 mA
with increasing voltage to a maximum of 350 V. Approximately 1.0
g of protein was loaded per lane. Gels were silver-stained (Silver
Stain Plus Kit, Bio-Rad), scanned, and photographed with a scanning
densitometer (Fluor-S MultiImager, Bio-Rad), after which bands were
quantified using Quantity One software (Bio-Rad). MyHC I, IIA, and
IIX isoforms were expressed proportionally to each other.
Data collection. Quadriceps muscle endurance was calculated in
three ways: by measuring peak force generated for each train both
manually and from automated digital processing at predetermined
time points (10, 20, 30, 40, and 50 trains); by the time for the force
generated by the muscle to fall to a percentage of baseline; and by
integrating the force generated to calculate the force time index (kg/s).
Statistical analysis. Data are expressed as means  SD. Variables
were compared between groups using unpaired t-tests. Possible cor-
relations between quadriceps endurance and muscle biopsy results
were evaluated using a Pearson correlation. A P value of 0.05 was
taken to be significant, except for the analyses of force generation at
multiple time points where, since multiple end points were available,
we sought P  0.01. A statistical software package was used for all
calculations (Statview; SAS Institute; Cary, NC). Where necessary,
low-frequency quadriceps fatigue was defined as a fall in the unpo-
tentiated TwQ of 15%; this figure, which to some extent is arbitrary,
Fig. 1. Study protocol. TwQ, quadriceps
twitch force measured by supramaximal fem-
oral nerve magnetic stimulation. QMVC, quad-
riceps maximal isometric voluntary contrac-
tion.
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has been used by other investigators (e.g., Ref 31), although it should
be noted that they have measured potentiated twitches. A Bland-
Altman plot was used to assess reproducibility, and the intraclass
correlation coefficient was calculated separately for patients and
control subjects.
RESULTS
Patient characteristics. The characteristics of the subjects
are shown in Table 1. The patient and control groups were well
matched with respect to age and body composition. The pa-
tients with COPD had severe disease as defined by the GOLD
criteria [mean  SD of forced expiratory volume for 1 s
(FEV1) 24.8  4.04% predicted]. Quadriceps strength mea-
surements, when assessed using twitch force or maximal vol-
untary contraction force, were numerically lower in the COPD
group than the control group, but the differences did not reach
statistical significance.
Quadriceps force and endurance measurements. Force was
continuously measured during the rMS endurance protocol. An
example of a subject’s force recording is shown in Fig. 3. In all
subjects, there was task failure manifest by failure of the
quadriceps muscle to maintain force during the rMS endurance
protocol. As expected, the COPD group fatigued more rapidly
than the control subjects (Fig. 4). The decline in quadriceps
force was significantly different between the two groups at 10,
20, 30, and 40 trains (P  0.01 at each time point). The force
measurements themselves were analyzed in three ways (peak
force measurements manually, peak force produced from dig-
ital processing, and integrated values for each train); however,
the different methods yielded similar information, and we
opted to use the peak force measured manually for all further
analyses as we considered this the most likely approach to be
used in clinical practice.
Time for the force to fall to 70% of baseline (T70) was
shorter in the COPD group than the control group, 55.6  26.0
vs. 121  38.7 s (P  0.0014) (Fig. 5). Nine subjects had two
measurements of quadriceps endurance performed at least 1 wk
apart to assess reproducibility. Figure 6 shows a Bland-Altman
plot of the agreement between results of the separate visits. In
all subjects there was acceptable repeatability with all of the
differences falling between 95% confidence intervals. The
intraclass correlation coefficient R for measuring T70 was 0.90
for the controls and 0.96 for the patients, indicating excellent
reproducibility.
Low-frequency fatigue. TwQ was measured before and at 10
min after the endurance protocol. None of the control subjects
Fig. 2. Schematic diagram of equipment setup for the endurance run using
repetitive magnetic stimulation, and a picture of the quadriceps coil wrapped
around the muscle of a subject.
Table 1. Subject demographics
COPD (n  8) Controls (n  8)
Age, yr 61.0 (6.3) 60.0 (10.9)
Height, cm 177 (4.3) 177 (8.5)
Weight, kg 78.1 (17.7) 87.4 (11.0)
BMI, kg/m2 24.9 (5.7) 27.9 (3.8)
FFM, kg 57.1 (9.3) 64.2 (7.0)
FFMI, kg/m2 18.2 (3.0) 20.4 (1.8)
FEV1, liters 0.89*(0.20) 3.27 (1.12)
FEV1, % predicted 24.8*(4.0) 95.5 (20.7)
FVC, liters 3.90 (0.72) 4.01 (0.94)
FVC, % predicted 86.6 (17.5) 92.9 (13.0)
FEV1/FVC 23.2*(6.3) 80.5 (9.2)
TLCO, % predicted 36.1 (10.7)
QMVC, kg 36.5 (11.9) 44.8 (12.2)
QMVC/FFM, % 69.9 (18.4) 64.8 (21.5)
TwQ, kg 8.11 (2.73) 9.73 (2.71)
Values are expressed as means (SD). COPD, chronic obstructive pulmonary
disease; BMI, body mass index; FFM, fat-free mass; FFMI, FFM index, FEV1,
forced expiratory volume in 1 s; FVC, forced vital capacity; TLCO, carbon
monoxide transfer factor; QMVC, quadriceps maximal voluntary contraction;
TwQ, quadriceps twitch force. *P  0.05 compared with controls.
Fig. 3. An example of a subject’s quadriceps force produced during repetitive
magnetic stimulation (rMS) over 50 trains. The peak force was measured for
each train to detect force decline.
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but four of the eight COPD patients showed evidence of
low-frequency fatigue (Table 2) using the 15% criteria. Stimuli
were not accepted for this analysis if the CMAP was 10%
different from the pre-rMS values; the total number of stimuli
rejected was 0 or 1 of 7 in all cases save one, where 3 of 7 were
discarded. The reproducibility of the fall in TwQ is shown in
Table 3; the two patients with the greatest fall (P7 and P8) on
the first occasion are also the two with the greatest fall on the
second occasion.
Muscle biopsy analysis. The quadriceps muscle biopsy data
are displayed in Table 4. Oxidative capacity was lower in the
COPD group than the controls [CS-to-PFK ratio (CS/PFK)
0.07  0.03 vs. 0.13  0.41, P  0.007]. There was a
reduction in the expression of MyHC type I (29.4  11.8% vs.
48.1  6.4%, P  0.002) and an increase in expression of
MyHC type IIA (54.5  12.7% vs. 38.3  6.1%, P  0.006)
in the COPD group compared with controls. Positive correla-
tions were observed between T70 and %MyHC type I (r 
0.68, P  0.004) and between T70 and CS/PFK (r  0.67, P 
0.005), as illustrated in Fig. 7. There was only a poor correla-
tion noted between quadriceps strength TwQ and CS/PFK (r 
0.177, P  0.512) and TwQ and %MyHC type I (r  0.279,
P  0.296).
Physical activity questionnaire. Patients with COPD re-
ported reduced physical activity compared with control sub-
jects when questionnaires were analyzed for total activity time
(11.2  7.5 vs. 33.2  13.6 h/wk, P  0.001) and subjects’
estimated weekly energy expenditure (2,400  1,740 vs.
7,980  3,820 kcal/wk, P  0.002). Estimated energy ex-
pended correlated significantly with FEV1 (r  0.58, P 
0.024), TwQ (r  0.57, P  0.022), T70 (r  0.55, P  0.027),
and with biopsy features (%MyHC type I, r  0.53, P  0.035)
considering patients and controls taken together.
DISCUSSION
The main finding of this study is that quadriceps endurance,
assessed using rMS, can be safely and reproducibly measured
in healthy older humans and in patients with a serious medical
condition (COPD). We observed that endurance was reduced
in patients with COPD compared with age-matched control
subjects. The reduced endurance seen in the COPD patients
was associated with a reduced proportion of type I fibers and a
reduced ratio of oxidative to glycolytic enzymes, confirming
the biological validity of the measurement. This technique
provides a well-tolerated method to assess quadriceps endur-
ance and therefore could be useful for future clinical studies.
Critique of method. A weakness of our study is that the
cause of force loss is not clear. Evidence of low-frequency
fatigue was observed in half of the COPD patients and none of
the controls. Since rMS aimed to generate 30% of maximum
voluntary contraction (MVC), the greatest fall in TwQ that we
could have observed was 30%, and it follows that TwQ could
be a relatively insensitive test for a protocol that only stimu-
lates a portion of the muscle; we therefore believe that low-
frequency fatigue is the most likely cause of failure of tension
generation. Interestingly, in our original description of the
technique (30), we applied a demanding voluntary protocol in
which the entire muscle was activated. The mean fall in
unpotentiated TwQ observed was 45%. Had a similar protocol
been applied to one-third of the muscle, we should expect the
fall in TwQ to be 15%, which may explain why none of the
controls and only four of eight patients reached this threshold.
Fig. 4. Force decline during the repetitive magnetic stimulation endurance
protocol. The curves were significantly different at 10, 20, 30, and 40 trains.
COPD, chronic obstructive pulmonary disease.
Fig. 6. Bland-Altman plot displaying the agreement between results from the
repeated tests in 4 COPD patients and 5 control subjects. The mean difference
between visits (0.28 s) is marked by the continuous line, and all subjects lie
within the 95% confidence intervals (marked with the dashed lines).
Fig. 5. Time for the force to fall to 70% of baseline (T70) in the 2 subject
groups. The mean T70 are marked with a line and are significantly different,
P  0.0014.
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Nevertheless, it proved impossible to confidently obtain
CMAPs during rMS because of artefact, and therefore a con-
tribution from high-frequency fatigue or transmission failure
cannot be absolutely excluded.
In our study the difference in baseline quadriceps strength
between the two groups did not reach statistical significance,
most likely because of the small sample size. In a larger study
by Man et al. (22), quadriceps strength measured using single
Table 2. Muscle contractility before and after the rMS protocol
Patient No.
QMVC, kg TwQ, kg
TwQ, %
CMAP, mV
Before After Before After Before After
Patients
P1 46.9 36.2 6.3 6 5 1.08 1.19
P2 44.2 40.6 12.1 12.4 2 1.83 1.77
P3 37.9 32.4 6.6 5.4 18 5.12 4.96
P4 32.9 33.8 11.2 10.8 4 4.83 4.62
P5 29.3 23.8 9.2 7.2 22 4.06 3.97
P6 33.7 32.5 12.7 10.9 14 2.49 2.72
P7 32.8 31.4 10.8 8.1 25 2.25 2.46
P8 44.1 37.9 12.1 9.2 24 6.52 5.99
Mean 37.7 33.6 10.1 8.7 14 3.53 3.46
SD 6.6 5 2.5 2.5 10 1.89 1.68
Controls
C1 52.8 42.3 8.9 10.2 15 6.18 6.89
C2 29.9 27.1 8.0 7.2 10 2.67 2.49
C3 57.9 49.1 8.8 7.7 13 5.41 4.93
C4 55.8 45.2 13.3 13.8 4 4.24 3.88
C5 43 35.7 8.2 7.7 6 3.99 3.92
C6 51.3 57.4 10.7 13.2 23 7.12 6.49
C7 45.3 37.5 9.3 8.4 10 8.83 8.28
C8 34.3 31.5 12.9 12.4 4 3.67 3.89
Mean 46.3 40.7 10.0 10.1 0 5.26 5.10
SD 10.1 9.8 2.1 2.7 13 2.04 1.94
rMS, repetitive magnetic stimulation; CMAP, compound muscle action potential. P1–P8, COPD patients; C1–C8, control subjects.
Table 3. Reproducibility of changes in TwQ after endurance protocol was performed on 2 occasions in 4 patients and 5
control subjects
Patient No.
Stimuli Before Protocol Stimuli After Protocol
Fall in TwQ, %QMVC, kg TwQ, kg CMAP, mV QMVC, kg TwQ, kg CMAP, mV
Patient trial 1
P4 32.9 11.2 4.83 33.8 10.80 4.62 4
P6 33.7 12.7 2.49 32.5 10.90 2.72 14
P7 32.8 10.8 2.25 31.4 8.08 2.46 25
P8 44.1 12.1 6.52 37.9 9.18 5.99 24
Patient trial 2
P4 34.1 11.7 3.95 32.8 10.6 3.69 9
P6 28.5 9.12 3.07 26.4 9.33 3.13 2
P7 27.5 9.48 1.41 25.8 7.81 1.28 18
P8 42.3 11.5 5.38 37.7 9.2 4.64 20
Control trial 1
C1 52.8 8.88 6.18 42.3 10.20 6.89 15
C2 29.9 8.01 2.67 27.1 7.17 2.49 10
C3 57.9 8.83 5.41 49.1 7.72 4.93 13
C4 55.8 13.3 4.24 45.2 13.80 3.88 4
C8 34.3 12.9 3.67 31.5 12.40 3.89 4
Control trial 2
C1 46.6 10.4 4.81 46.1 10.3 4.60 1
C2 32.5 7.9 3.91 34.7 7.5 3.63 6
C3 49.3 7.9 4.76 46.3 7.93 4.41 0
C4 55.2 13.7 6.93 54.0 12.8 7.02 7
C8 44.4 11.6 4.67 42.0 10.7 4.33 8
Note that the two patients with the greatest fall in TwQ on the first trial (P7 and P8) also do so on the second trial.
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femoral nerve magnetic stimulation was reduced in patients
with COPD compared with controls with values of 7.1 (2.2) vs.
10.0 (2.7) kg. To control for the variable strength of the
subjects, the stimulation intensity was adjusted to achieve 30%
of baseline QMVC so that differences in muscle mass and
strength would not influence the degree of task failure. Quad-
riceps strength is mainly related to muscle mass (5, 11), but
endurance, at least when previously measured using volitional
protocols, is reduced in COPD patients regardless of muscle
mass (1). However, we did find reduced endurance using rMS
that related to the alterations in the enzyme capacity and
fiber-type distribution in the quadriceps with a correlation that
was superior to that observed between strength measurements
and biopsy features. This indicates that rMS may be a more
sensitive marker of skeletal muscle dysfunction and that this
method of assessing quadriceps muscle dysfunction may be
superior to strength testing for the detection of small changes
in fiber-type proportion. This is in keeping with the finding of
Van’t Hul et al. (35) in COPD where, compared with control
subjects, MVC was reduced by 20–30% whereas performance
on a volitional endurance test was reduced by 70–80%.
A potential critique of our study is that the patient is required
to generate an MVC to calibrate the intensity of the rMS
protocol. However, because in most skeletal muscles (23),
including the quadriceps (30), the unpotentiated twitch tension
is 	20% of the MVC, the alternative, for patients unable to
generate an MVC, would be to run the rMS protocol aiming to
generate 150% of the unpotentiated TwQ.
The duty cycle (0.4) we adopted was influenced by the
approach of Burke et al. (7), who studied isolated muscle
fatigue using electrical stimulation. They recorded mechanical
and electrical responses in the cat gastrocnemius muscle during
repeated tetanization using trains lasting 330 ms every second,
i.e., a duty cycle of 0.33, at a frequency of 40 Hz to assess
muscle fatigue. They observed that the tension produced de-
clined significantly after 30 trains. We selected a stimulation
frequency of 30 Hz because it is representative of motor neuron
firing frequencies during strong human skeletal muscle con-
tractions; 20 Hz is the level at which the femoral nerve motor
neurons discharge for ambulation while 40 Hz is analogous to
sprinting (14).
Skeletal muscle fatigue is defined as a reversible loss of the
capacity to generate force resulting from activity under load
(3). Low-frequency fatigue results in loss of force generation in
response to low stimulation frequencies (20 Hz). An ac-
cepted method to detect low-frequency fatigue in clinical
studies is to measure the force elicited from a single stimulus.
A number of investigators have confirmed that a twitch elicited
by magnetic stimulation of the femoral nerve can be used to
detect fatigue (20, 30). It is important to note that a fall in the
twitch quadriceps tension only indicates contractile fatigue as
a consequence of excitation-contraction coupling if there is no
documented change in the CMAP amplitude; otherwise it may
be due to transmission failure.
Any measurement of muscle fatigue depends on the stimu-
lation paradigm used, so it is difficult to compare our method
of repetitive magnetic stimulation with whole body exercise or
isolated quadriceps exercise. The ventilatory limitation that
occurs with effort-dependent exercise can curtail endurance
tests so that quadriceps muscle fatigue may not be evident at
Table 4. Muscle biopsy data
COPD (n  8) Controls (n  8)
Oxidative enzymes, U/g protein
CS 19.5 (8.6) 36.2 (27.2)
HAD 18.8*(6.9) 35.2 (19.7)
Glycolytic enzymes, U/g protein
PFK 293 (157) 292 (221)
GlyP 975 (521) 1,030 (648)
CS/PFK 0.07*(0.03) 0.13 (0.41)
HAD/PFK 0.07*(0.03) 0.15 (0.07)
MyHC I, % 29.4*(11.8) 48.1 (6.4)
MyHC IIA, % 54.5*(12.7) 38.3 (6.1)
MyHC IIX, % 16.1 (7.4) 13.6 (8.2)
Values are expressed as means (SD). CS, citrate synthase; HAD, hydroxya-
cyl-CoA dehydrogenase; PFK, phosphofructokinase; GlyP, glycogen phos-
phorylase; CS/PFK, CS-to-PFK ratio; HAD/PFK, HAD-to-PFK ratio; MyHC
I, IIA, and IIX are myosin heavy chain isoforms I, IIA, and IIX. *P  0.05
compared with controls.
Fig. 7. Correlations between strength and en-
durance properties and muscle biopsy analysis.
Positive correlations were observed between
T70 and percentage of myosin heavy chain type
I (%MyHC I) (r  0.68, P  0.004) and
between T70 and citrate synthase-to-phospho-
fructokinase ratio (CS/PFK) (r  0.67, P 
0.005). Weaker correlations were observed be-
tween TwQ and %MyHC I (r  0.279, P 
0.296) and between TwQ and CS/PFK (r 
0.177, P  0.512).
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the time of exercise termination; indeed, recent data suggest
that the occurrence of quadriceps fatigue is a determinant of the
cause of exercise limitation (31) and also, in part, is a deter-
minant of the efficacy of bronchodilators (27). These problems
are largely circumvented with rMS. We could have compared
rMS with a volitional protocol (e.g., repeated voluntary efforts
at 30% MVC), but this would not have been a fair comparison
because the brain is able, by varying firing rate and recruit-
ment, to preserve 30% force output for a considerable period of
time. For example, even in a study in which normal subjects
were required to sustain a 50% maximal quadriceps effort
continuously (i.e., a duty cycle of 1.0), the mean endurance
time was 78 s (21). Therefore, in the present study we chose to
compare endurance with biopsy findings.
Physiological results and muscle biopsy findings. It is well
established that, when patients with advanced COPD are com-
pared with control subjects, there is an excess of type II fibers
and a reduction in oxidative enzymes (13, 17). Physiologically,
one would expect such changes to result in reduced quadriceps
endurance. Thus, at one level, our data may be considered
unsurprising, but our data are, to our knowledge, the first time
that a new physiological test of muscle function has been
validated by comparison with biopsy data.
Significance of findings. Our method is shown to be practical
in the sense that it was tolerated by patients with advanced
COPD. The stimulation coil used for this study, like previous
coils used in magnetic stimulation, has a tendency to heat up.
In practice, if several patients need to be tested in close
succession, this can be resolved by the use of fans to cool the
coil or by having a second coil. In the longer term, technical
advances to actively cool the coil (e.g., Ref. 25) may reduce
overheating. The technique was shown to be reproducible
(Fig. 6).
We describe a novel method for assessing quadriceps fatigue
in patients with COPD that is acceptable to patients and that
correlates with muscle biopsy data. Since this method of
assessing quadriceps endurance is not subject to motivation, is
reproducible, and relates to fiber-type proportions, we believe
it could have particular relevance to patients in the intensive
care unit or in patients unable to perform a maximal effort for
neurological or other reasons. Peripheral muscle dysfunction is
an important consequence of critical illness neuromuscular
abnormality (18), and our technique could be used to measure
it before the patient is clinically able to cooperate.
Previous work has suggested that the magnitude of quadri-
ceps dysfunction amongst COPD patients varies depending on
the severity of disease (35). We chose to study patients with
severe disease, and there is a large difference in reported
physical activity between such patients and normal subjects
that has been confirmed elsewhere using objective measures
(28). It is therefore not surprising that we have seen such a
clear difference in the endurance and biopsy results. The
sample size was not large enough for us to be able to draw
conclusions on the relationship between lung function and
quadriceps endurance; however, the results do suggest that
reduced endurance is linked with other features in the quadri-
ceps known to be associated with COPD, specifically fiber-
type shift and enzyme content. It is known that physical
activity is reduced in COPD patients (28); however, the rela-
tionship between physical activity and quadriceps strength is
modest. We found that the patients had reduced endurance
judged by rMS and speculate that reduced endurance may be a
contributory factor to the reduced activity displayed by COPD
patients.
Endurance was significantly reduced in COPD patients.
Although the relationship between fiber-type proportion and
T70 was reasonably strong considering COPD patients and
normal subjects together (Fig. 7), it would have been less
convincing had the COPD patients been considered in isola-
tion. We speculate that the correlation could have been closer
had we studied and biopsied the same leg, but this would have
been impractical in a single session. Moreover, the available
data do not suggest a large role for handedness in determining
fiber-type composition (19). In future studies, it will be nec-
essary to study patients with milder quadriceps involvement to
clarify the threshold at which our technique can usefully detect
differences between health and disease.
In summary, this study describes a novel, effort-indepen-
dent, and reproducible technique for quantifying quadriceps
muscle endurance that is feasible in patients with advanced
medical disease. The data confirm increased fatigability in
patients with COPD. The validity of the fatigue findings with
this technique are supported because reduced endurance was
associated with reduced type I fibers and reduced oxidative
enzymes. rMS is a sensitive in vivo method for the assessment
and quantification of quadriceps endurance that is feasible in
health and disease.
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